Type 2 diabetes and depression via microvascular dysfunction, neurodegeneration, inflammation, advanced glycation end products (AGEs), arterial stiffness

Publication date

2025-09

Authors

Steens, Indra L M
Schram, Miranda T
Houben, Alfons J H M
Berendschot, Tos T J M
Koster, Annemarie
Bosma, Hans
Eussen, Simone J P M
de Galan, Bastiaan E
van Sloten, Thomas T

Editors

Advisors

Supervisors

Document Type

Article
Open Access logo

License

No license information available

Abstract

AIMS: Type 2 diabetes increases the risk of depression, but the mechanisms underlying this association are incompletely understood. We investigated whether microvascular dysfunction, neurodegeneration, low-grade inflammation, advanced glycation end products (AGEs) and arterial stiffness, pathologies that are more common in diabetes, explain, or mediate the association between type 2 diabetes and incident clinically relevant depressive symptoms. MATERIALS AND METHODS: We used prospective data from The Maastricht Study, a population-based cohort study. Diabetes status and potential mediators were assessed at baseline. Clinically relevant depressive symptoms (PHQ-9 score ≥10) were assessed at baseline and each year during a median of 8.1 (IQR 4.2, 10.1) years of follow-up. Mediation analysis was employed to investigate the mediating effect of microvascular dysfunction (retinal, blood and MRI biomarkers), neurodegeneration (retina and MRI biomarkers), low-grade inflammation (blood biomarkers), AGEs (skin and blood biomarkers) and arterial stiffness (tonometry and ultrasound biomarkers). RESULTS: Data of 6091 participants (age, 59.4 years [SD 8.6]; 51.3% women; 23.6% type 2 diabetes) were available. Type 2 diabetes was associated with a higher incidence of clinically relevant depressive symptoms (HR:1.37; 95% CI 1.13, 1.65). This association was partly mediated by microvascular dysfunction (proportion mediated:10.4% [95% CI:3.6%, 17.2%]); neurodegeneration (proportion mediated:12.1% [95% CI: 3.9%, 20.3%]); AGEs (proportion mediated:5.4% [95% CI: 3.0%, 8.8%]); and arterial stiffness (proportion mediated:8.4% [95% CI: 3.3%, 13.5%]); but not by low-grade inflammation. CONCLUSIONS: The association between type 2 diabetes and a higher risk of clinically relevant depressive symptoms is partly mediated by microvascular dysfunction, neurodegeneration, AGEs and arterial stiffness.

Keywords

cardiovascular disease, diabetes complications, population study, type 2 diabetes, Internal Medicine, Endocrinology, Diabetes and Metabolism, Endocrinology, Journal Article

Citation

Steens, I L M, Schram, M T, Houben, A J H M, Berendschot, T T J M, Koster, A, Bosma, H, Eussen, S J P M, de Galan, B E & van Sloten, T T 2025, 'Type 2 diabetes and depression via microvascular dysfunction, neurodegeneration, inflammation, advanced glycation end products (AGEs), arterial stiffness', Diabetes, Obesity & Metabolism, vol. 27, no. 9, pp. 4847-4858. https://doi.org/10.1111/dom.16527